DUBLIN--(BUSINESS WIRE)--Aug 23, 2018--The "Asia-Pacific Heart Pump Devices Market - Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Asia-Pacific heart pump devices market is expected to reach USD 756.15 million by 2025 and is projected to register a healthy CAGR in the forecast period 2018 to 2025.

Prominent factors driving the growth of this market consist of increasing incidence of cardiac disease, rapid advancement in surgical technique in VAD implantation, increasing popularity of minimal invasive surgical procedures in cardiology, regulatory approval of heart pump devices are fuel the growth of heart pump devices market.

On the basis of product the Asia-Pacific heart pump devices market is segmented into ventricular assist devices, intra-aortic balloon pump, total artificial heart (TAH). In 2018, intra-aortic balloon pumps are expected to dominate the Asia-Pacific heart pump devices market with highest market shares. However, ventricular assist devices are expected to grow at the highest CAGR in the forecast period.

On the basis of type the Asia-Pacific heart pump devices market is categorized into implantable heart pump devices and extracorporeal heart pump devices. In 2018, implantable heart pump devices are expected to dominate the Asia-Pacific heart pump devices market with the highest CAGR in the forecast period 2018 to 2025.

On the basis of therapy Asia-Pacific heart pump devices market is segmented into bridge-to-transplant (BTT), bridge-to-candidacy (BTC) destination therapy and others. In 2018, bridge-to-transplant (BTT) are expected to dominate the Asia-Pacific heart pump devices market with the highest CAGR in the forecast period 2018 to 2025.

Market Dynamics

Drivers

Increasing Incidence of Cardiac Diseases Increasing Regulatory Approval & Reimbursement Procedure of Heart Pump Devices Rapid Advancement in Surgical Technique for VAD Implantation Increasing Popularity of Minimally Invasive Surgical Procedures in Cardiology

Restraint

High Cost of Process & Product

Opportunity

Emerging Countries

Challenge

Complications Related to LVAD

Companies Profiled

Abbott Getinge AB Teleflex Incorporated Abiomed Berlin Heart BiVACOR Inc. Calon Cardio CardiacAssist Inc. Jarvik Heart Inc. Medtronic ReliantHeart Inc. SynCardia Systems LLC Terumo Corporation Thoratec Corporation

For more information about this report visit https://www.researchandmarkets.com/research/x7fb2r/the_heart_pump?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180823005368/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Cardiovascular Devices

KEYWORD: ASIA PACIFIC

INDUSTRY KEYWORD: HEALTH CARDIOLOGY MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/23/2018 08:01 AM/DISC: 08/23/2018 08:02 AM

http://www.businesswire.com/news/home/20180823005368/en